 |
|
|
 |
|
|
|
|
| March 27, 2003 |
|
| Mitsubishi Kagaku Iatron, Inc. to be established |
|
Mitsubishi Chemical Corporation (Head office: Chiyoda-ku, Tokyo; President: Ryuichi Tomizawa) announced that three of its health care subsidiaries would be merged on July 1, 2003. The three companies concerned are Iatron Laboratories, Inc., Dia-Iatron Co., Ltd., and Mitsubishi Kagaku Medical, Inc., all of which are involved in the clinical diagnostic industry. The new company, Mitsubishi Kagaku Iatron, Inc. will concentrate on development, production, import and export, and sales of clinical diagnostic products, clinical diagnostic instruments, and reagents, and so on. The outline of the company is as follows:
| (1) |
Company name: Mitsubishi Kagaku Iatron, Inc. |
| (2) |
Date of merger: July 1, 2003 |
| (3) |
| Business: |
Development, production, sales, and import and export of the following:
Clinical diagnostic products
Clinical diagnostic instruments
Reagents, etc. |
|
| (4) |
Head office: 11-4, Higashi Kanda 1-chome, Chiyoda-ku, Tokyo
Branch office: Tokyo, Osaka, Nagoya, and others
Plant: Yachiyo (Chiba), Tsukuba (Ibaraki)
Research center: Narita (Chiba) |
| (5) |
Capital: 300 million yen |
| (6) |
Total assets: About 13 billion yen |
| (7) |
Ownership shares: MCC, 75.1%; Others, 24.9% |
| (8) |
President and CEO: Toshihiko Yoshitomi |
| (9) |
Employees: About 420 |
| (10) |
Sales: About 14.5 billion yen in the 2004 fiscal year |
| For further information, please contact |
| Public Relations and Investor Relations Dept., |
| Mitsubishi Chemical Corporation |
| Tel: [+81]-(0)3-3283-6274 |
|
|
|
 |
|
|
|
